Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from January through March, 2019, will discuss HIV treatment, complications/side effect management and prevention strategies.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

These educational Quarterly Briefs will discuss changing guidelines, evolving treatment options, and side-effect considerations in the management of patients with HIV as well as an update on HIV prevention.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV through a series of ‘what you need to know in 5-minutes’ videos from HIV Drug Therapy, Glasgow.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

These educational Quarterly Briefs will discuss changing guidelines, evolving treatment options, and side-effect considerations in the management of patients with HIV.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV and viral hepatitis through a series of daily, ‘what you need to know in 5-minutes’ videos from the 22nd International AIDS Conference (AIDS 2018) in Amsterdam, The Netherlands.

Activity Summary:
We are pleased to have recently held the Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXVI (OPMAN). The conference took place March 23-25, 2018, in Orlando, Florida with 15 of the leading clinicians and researchers in HIV and hepatitis medicine presenting an array of topics covering HIV disease, hepatitis and HIV-hepatitis coinfection. The presentations offered a unique distillation of clinically focused data tailored for practicing HIV and hepatitis healthcare professionals.

These certified CME/CE enduring video archives of OPMAN XXVI provide access to each day of the conference, including the clinical presentations, interactive case discussions and panel discussions addressing audience and faculty questions. CME/CE credit is provided separately by section so you can participate in only those sections of interest to you. We hope you enjoy this activity.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV through a series of ‘what you need to know in 5-minutes’ videos, and a 1-hour webcast with data from each day of the CROI 2018.

Activity Summary:
This certified CME/CNE Interactive Case Review will address epidemiologic trends using a case-based approach to discuss optimal HCV therapy options and management approaches/challenges for patients with these various conditions.

Dr. Brown and Dr. Sulkowksi will discuss screening, prevention and treatment of hepatitis C virus (HCV) infection among special patient populations. Approaches necessary to achieve successful treatment of HCV in patients with HBV coinfection, HIV coinfection, advanced liver disease, and concomitant renal disease will be reviewed. Each Interactive Case has thought-provoking questions from the faculty built into the end giving users the opportunity to test their understanding of the material presented.

Activity Summary:
Management of the HIV/hepatitis-coinfected patient requires a multidisciplinary approach tailored to the treatment needs of HIV, hepatitis infection, or both and the potential ability of the patient to adhere to and tolerate treatment.

These educational mini modules will describe the epidemiology and significance of liver disease and hepatitis in HIV, explain the impact of ART on liver disease, and discuss current approaches to treating HCV and HBV infection in patients with HIV disease.

Activity Summary:
As therapy and our understanding of the HIV disease process progresses, so do our management approaches, as noted by the multiple updates issued by the DHHS and IAS-USA on their guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Guideline updates such as these have a rapid impact on application to clinical practice, affecting treatment strategies and preferences in HIV patient management. New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of HIV treatment as HIV prevention and development of long-acting novel agents.

This Conversations in HIV will discuss evolving treatment options in HIV, such as the benefits and risks of 2 vs 3 drug therapy, integrase inhibitor vs protease inhibitor use and what’s on the horizon in antiretroviral therapy.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV and related comorbidities through a series of daily, ‘what you need to know in 5 minutes’ videos each day from the 2017 European AIDS Clinical Society (EACS) Conference in Milan, Italy.

Activity Summary:
A number of organizations have recommended the use of PrEP to people at greatest risk of HIV acquisition. However there remains a significant gap between proving efficacy in clinical trials and achieving effectiveness in the real-world setting. Although clinical trial data provide an initial framework for the efficacy and safety of PrEP, a number of questions and concerns remain about how to use PrEP in everyday clinical practice as well as its impact on reducing HIV incidence.

These educational mini modules discuss the lessons learned from PrEP demonstration projects and open-label extension studies on approaches to mitigate potential barriers to PrEP uptake and strategies to improve integration of PrEP into existing clinical practices.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Mini Modules cover data from IAS 2017 including epidemiologic trends, prevention strategies, recommendations for therapy, future ARV therapy, and HIV comorbidity management.

Activity Summary:
Because the field of ART continues to evolve rapidly and best practice changes over time, there is a need for those treating HIV infections to consider expert opinion and guidelines in the context of the needs and beliefs of individual patients to tailor therapy and achieve best results.

These educational mini modules include new advances in care, what antiretrovirals to select for different types of patients, prevention, and emerging trends impacting the clinical management of HIV patients.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Individualizing HIV for simplified and convenient regimens challenges caregivers to systematically evaluate a number of factors, including pill burden, potential toxicities, lifestyle changes, and psychosocial circumstances. The need for simplified ART is recognized by recent treatment guidelines published by the Department of Health and Human Services and the International AIDS Society-USA.

These educational mini modules outline the relationship between virologic efficacy and adherence to ART, identify the factors that can affect adherence to ART regimens, and describe the strategies to simplify ART and improve or facilitate ART adherence.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.